HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
ADMA Biologics, Inc. (ADMA)
2.91  0.04  (1.39%) 08-13 00:51
Open: 2.93 High: 2.96
Pre.close: 2.87 Low: 2.8
Volume: 3,152,020 Ave vol: 4,193,170
52w High: 5.484 52w Low: 1.45
MA(50): 3.016 MA(200): 3.01
EPS: -0.881 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.admabiologics.com
Market Cap (M): 251
Shares Out (M): 86
ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc.
Technical analysis
Overall: Neutral
MA: Bullish MACD: Bearish
KDJ: Bullish RSI: Bullish
Target 1: 4.24 Target 2: 4.91
Resist 1: 3.63 Resist 2: 4.20
Support 1: 2.71 Support 2: 2.26
Company key metrics
Revenue per Share: 0.54
Net Income per Share: -0.8883
Cash per Share: 0.4922
Book Value per Share: 0.482
Price to Sales: 7.5553
Price to Book Value: 8.4656
Earnings Yield: -0.2177
Dividend Yield: 0
Debt to Equity: 3.8521
Debt to Assets: 0.7939
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts
Headline news
Wed, 12 Aug 2020
Is ADMA Biologics, Inc. (ADMA) a Keeper? Bullish Price Target $15.00 - The News Heater

Tue, 11 Aug 2020
ADMA Biologics Inc (NASDAQ:ADMA) Posts A Growth Of 19% In Q2 2020 Revenues - BP Journal

Mon, 10 Aug 2020
Did Hedge Funds Make The Right Call On ADMA Biologics Inc (ADMA) ? - Yahoo Finance

Mon, 10 Aug 2020
ADMA Biologics Inc. (ADMA) Open at price of $2.91: A Brand-New Opportunity for Investors - News Daemon

Mon, 10 Aug 2020
Gear up for the change! ADMA Biologics Inc. (ADMA) has hit the volume of 4206343 - The InvestChronicle

Wed, 05 Aug 2020
ADMA Biologics Inc (ADMA) Q2 2020 Earnings Call Transcript - Motley Fool

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.